Results 161 to 170 of about 76,842 (216)
Some of the next articles are maybe not open access.
Hematopoietic Stem Cell Transplantation
Hospital Practice, 1993The isolation, purification, and in vitro expansion of the hematopoietic stem cell have allowed pretransplant immunologic and genetic manipulation. As a result, rapid allogeneic or autologous hematologic reconstitution with minimal graft-versus-host disease is possible in patients receiving high-dose chemotherapy.
S, Jagannath, B, Barlogie, G, Tricot
openaire +2 more sources
Mesenchymal Stem Cells and Hematopoietic Stem Cell Transplantation
Annals of the New York Academy of Sciences, 2003Abstract: Techniques have recently beome available to isolate and grow mesenchymal progenitors and to manipulate their growth under defined in vitro culture conditions. As a result mesenchymal stem cells can be rapidly expanded to numbers that are required for clinical application.
Willem E, Fibbe, Willy A, Noort
openaire +2 more sources
Tacrolimus in hematopoietic stem cell transplantation
Expert Opinion on Drug Metabolism & Toxicology, 2009Graft-versus-host disease (GVHD) associated with allogeneic peripheral blood or marrow transplantation is a serious life-threatening complication. Most of the available literature support the use of tacrolimus as a prophylactic agent for acute GVHD.To review the pharmacology, efficacy and safety of tacrolimus and recommend its place in therapy for the ...
Kara, Fortune, Daniel, Couriel
openaire +2 more sources
Hematopoietic Stem-Cell Transplantation
New England Journal of Medicine, 2006Hematopoietic stem-cell transplantation, which is used to treat both malignant and nonmalignant conditions, was first conceived more than 50 years ago, but problems associated with transplanting a nonsolid organ and modulating the immune response had to be solved before the procedure could be used clinically.
openaire +2 more sources
Hematopoietic Stem Cell Transplantation in Children
Critical Care Nursing Clinics of North America, 2011Medical and nursing care of the hematopoietic stem cell transplantation (HSCT) recipient are complex because of the pathophysiology, HSCT process, pre-HSCT conditioning regimens, numerous medications and therapies, acute and chronic complications, adverse effects, resources involved, and environmental considerations.
Julie A, Kolins +3 more
openaire +2 more sources